Pages that link to "Q70214523"
Jump to navigation
Jump to search
The following pages link to Contragestion with late luteal administration of RU 486 (Mifepristone) (Q70214523):
Displaying 18 items.
- Post-ovulatory contraception (Q34248034) (← links)
- Mifepristone. Separating fact from fiction (Q35156210) (← links)
- Mifepristone for luteal phase contraception (Q35617600) (← links)
- The possibility of using mifepristone for menstrual induction (Q35617603) (← links)
- RU486 and the early nineties (Q36926684) (← links)
- The Steroid Hormone Antagonist RU486: Mechanism at the Cellular Level and Clinical Applications (Q36928826) (← links)
- Medical methods to terminate early pregnancy (Q37976773) (← links)
- Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential (Q40486441) (← links)
- Contraception with anti-progesterone (Q41060724) (← links)
- Antiprogestin Action on the Endometrium (Q41611365) (← links)
- Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy (Q52230887) (← links)
- 5 Heterosteroids and Drug Research (Q57382962) (← links)
- The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate (Q67299975) (← links)
- Postcoital contraception: myth or reality? (Q68305108) (← links)
- Medical termination of pregnancy (Q68541270) (← links)
- Late luteal administration of the antiprogesterone RU486 in normal women: effects on the menstrual cycle events and fertility control in a long-term study (Q68611852) (← links)
- Viable term pregnancy despite "subluteal" serum progesterone levels in the first trimester (Q72853251) (← links)
- Summary of evidence and research needs on the use of mifepristone in fertility regulation: consensus from the conference (Q75211935) (← links)